Gandhi Hospital

Telangana 500003

0 studies enrolling now · 4 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Type 2 Diabetes Mellitus, Ulcerative Colitis

Studies at this site

• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — Completed